These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9050078)

  • 1. Effects of ddC and AZT on locomotion and acoustic startle. I: Acute effects in female rats.
    Morse DE; Davis HD; Popke EJ; Brown KJ; O'Donoghue VA; Grunberg NE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):221-8. PubMed ID: 9050078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of perinatal AZT exposure on the acoustic startle response in adult rats.
    Melnick SM; Weedon J; Dow-Edwards DL
    Neurotoxicol Teratol; 2002; 24(6):773-81. PubMed ID: 12460660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What they say about nucleoside drugs.
    Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine.
    Agarwal RP; Wang W; Yo P; Han T; Fernandez M
    Biochem Pharmacol; 1999 Nov; 58(10):1603-8. PubMed ID: 10535751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice.
    Hostetler KY; Richman DD; Sridhar CN; Felgner PL; Felgner J; Ricci J; Gardner MF; Selleseth DW; Ellis MN
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2792-7. PubMed ID: 7695264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.
    Morris GW; Laclair DD; McKee EE
    Antivir Ther; 2010; 15(4):587-97. PubMed ID: 20587852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic toxicity of AZT and ddC administered as single agents and in combination to rats and mice.
    Thompson MB; Dunnick JK; Sutphin ME; Giles HD; Irwin RD; Prejean JD
    Fundam Appl Toxicol; 1991 Jul; 17(1):159-76. PubMed ID: 1655546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.
    Cui L; Locatelli L; Xie MY; Sommadossi JP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1228-34. PubMed ID: 9067308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys.
    Qian MX; Swagler AR; Mehta M; Vishwanathan CT; Gallo JM
    Pharm Res; 1992 Feb; 9(2):224-7. PubMed ID: 1313173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.
    Lake-Bakaar G; Mazzoccoli V; Dickman K; Lyubsky S
    Dig Dis Sci; 2001 Sep; 46(9):1853-63. PubMed ID: 11575436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.
    Viora M; Di Genova G; Quaranta MG; Boirivant M; Camponeschi B
    J Clin Immunol; 1998 Sep; 18(5):346-54. PubMed ID: 9793827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
    Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ
    Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions.
    Mattioli B; Giordani L; Quaranta MG; Viora M
    Life Sci; 2004 Mar; 74(18):2291-300. PubMed ID: 14987953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [[ABC of the antivirals] Project Inform].
    Sidahora; 1996; ():19-32. PubMed ID: 11364292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of anti-HIV nucleosides in microswine.
    Swagler AR; Qian MX; Gallo JM
    J Pharm Pharmacol; 1991 Dec; 43(12):823-6. PubMed ID: 1687578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice.
    Venerosi A; Valanzano A; Alleva E; Calamandrei G
    Teratology; 2001 Jan; 63(1):26-37. PubMed ID: 11169552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.